Brannan Andrew 4
4 · CIRRUS LOGIC, INC. · Filed Nov 18, 2025
Insider Transaction Report
Form 4
Brannan Andrew
EVP, Worldwide Sales
Transactions
- Exercise/Conversion
Common Stock
2025-11-14$78.00/sh+7,406$577,668→ 14,268 total - Sale
Common Stock
2025-11-14$119.39/sh−7,406$884,202→ 6,862 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-14−595→ 0 totalExercise: $68.56Exp: 2029-11-06→ Common Stock (595 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-14−7,406→ 0 totalExercise: $78.00Exp: 2031-03-03→ Common Stock (7,406 underlying) - Sale
Common Stock
2025-11-14$117.44/sh−595$69,877→ 6,862 total - Exercise/Conversion
Common Stock
2025-11-14$68.56/sh+595$40,793→ 7,457 total - Sale
Common Stock
2025-11-14$117.44/sh−912$107,105→ 5,950 total
Footnotes (4)
- [F1]This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 15, 2025.
- [F2]The price reported in Table I - Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.78 to $120.40. The reporting person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to any security holder of Cirrus Logic, Inc. or the staff of the SEC upon request.
- [F3]Only vested shares can be exercised under this option. 25% of the shares vested on 11/6/20; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 11/6/23.
- [F4]Only vested shares can be exercised under this option. 25% of the shares vested on 3/3/22; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 3/3/25.